Resolutions at Getinge’s Annual General Meeting

At the Annual General Meeting of Getinge AB held on 21 March 2013, the following was resolved.

Election of Board of Directors
Carl Bennet (Chairman), Johan Bygge, Cecilia Daun Wennborg, Carola Lemne, Johan Malmquist, Johan Stern and Maths Wahlström were re-elected as members of the Board.

Fees to the Board of Directors
It was resolved that remuneration to the Board of Directors shall amount to a total of SEK 3,675,000 excluding remuneration for Committee work, of which SEK 1,050,000 to the Chairman and SEK 525,000 to each of the other Board members elected by the Meeting who are not employees of Getinge Group. In addition hereto, the Meeting resolved that work in the Audit Committee shall be compensated with SEK 240,000 to the Chairman and SEK 120,000 to each of the other members, while work in the Remuneration Committee work shall be compensated with SEK 125,000 to the Chairman and SEK 92,000 to each of the other members.

Dividend
In accordance with the proposal of the Board of Directors and the CEO, the Annual General Meeting resolved to declare a dividend of SEK 4.15 per share. Tuesday 26 March 2013 was determined as record date for dividend.

Guidelines for Remuneration to Senior Executives
The Annual General Meeting approved the proposal of the Board regarding guidelines for remuneration to senior executives, which principally involve the following. Remuneration and other terms and conditions of employment for senior executives shall be based on market conditions and be competitive in all markets where Getinge operates, to ensure that competent and skillful employees can be attracted, motivated and retained. The total remuneration to senior executives shall comprise basic salary, variable remuneration, pensions and other benefits. The variable remuneration shall be limited and connected to predetermined and measurable criteria elaborated with the purpose to promote the long-term added value of the company. The Board shall retain the right to deviate from the guidelines if motivated by particular reasons on an individual basis.

For further information, please contact:

Johan Malmquist                                         Ulf Grunander
CEO, Getinge Group                                   CFO, Getinge Group
Tel: +46 10 335 55 33                                 Tel: +46 10 335 55 80
E-mail: johan.malmquist@getinge.com   E-mail: ulf.grunander@getinge.com

GETINGE GROUP is a leading global provider of products and systems that contribute to quality enhancement and cost efficiency in healthcare, care and research. We operate under the three brands of ArjoHuntleigh, GETINGE and MAQUET. ArjoHuntleigh focuses on patient mobility and wound management solutions. GETINGE provides solutions for infection control in healthcare and contamination prevention in biotechnology. MAQUET specializes in solutions, therapies and products for surgical interventions and intensive care.

Getinge AB discloses the information herein in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication on 21 March 2013 at 5 PM CET.